Global coronavirus death toll surpasses 2 million

2020 becomes deadliest year in U.S. history, CDC finds

The global coronavirus pandemic has claimed more 2 million lives around the world, according to the latest numbers from Johns Hopkins University.

As of 12:45 p.m ET Jan. 15, 2,000,905 people have succumbed to the deadly virus since the pandemic began almost a year ago.

The U.S. continues to lead the world in confirmed cases — more than 23 million — and deaths, with almost than 390,000. Globally, more than 93 million cases of the coronavirus have been reported.

The British government has banned travel from South America and Portugal to ensure a new variant of COVID-19 found in Brazil doesn’t derail the U.K.’s vaccination program, although there are no signs the variant has reached the country, Britain’s top transportation official said.

U.K. Transport Secretary Grant Shapps said the entry ban, which took effect Friday morning, was extended to passengers arriving from Portugal because many people who come to Europe from South America travel through Portugal.

ExploreAJC's full coronavirus coverage

“We don’t have cases at the moment, but this is a precautionary approach,” Shapps told the BBC. “We want to make sure that we do everything possible so that vaccine rollout can continue and make sure that it’s not disturbed by other variants of this virus.”

The announcement comes just a few weeks after many countries banned travel from the U.K. following the discovery in England of another, more contagious variant of the virus that has been blamed for a sharp rise in COVID-19 cases and deaths. Scientists have said there is no indication the U.K. variant reacts any differently to coronavirus vaccines.

On Friday, U.S. pharmaceutical company Pfizer confirmed it is temporarily reducing deliveries to Europe of its COVID-19 vaccine while it upgrades production capacity to 2 billion doses per year.

The EU Commission chief said she’d immediately called Pfizer’s CEO. But in an indication the issue might go beyond Europe, Canada’s government said it was also affected.

Line Fedders, a spokeswoman for Pfizer Denmark, said that to meet the new 2 billion dose target Pfizer is upscaling production at its plant in Puurs, Belgium, which “presupposes adaptation of facilities and processes at the factory which requires new quality tests and approvals from the authorities.”

“As a consequence, fewer doses will be available for European countries at the end of January and the beginning of February,” she said. “This temporary reduction will affect all European countries.”

Germany’s Health Ministry said Friday Pfizer had informed the European Commission, which was responsible for ordering vaccines from the company, that it won’t be able to fulfill all of the promised deliveries in the coming three to four weeks.

Pfizer’s Belgian plant supplies all shots delivered outside the United States, including Canada where procurement minister Anita Anand said Friday that the U.S. drug-maker is temporarily reducing deliveries because of issues with its European production lines. While the company said it still was able to deliver four million doses by the end of March, that is no longer guaranteed, she said.

Canada has received just 380,000 doses of the vaccine so far and was supposed to get another 400,000 this month, and is expecting almost two million doses in February.

Moderna COVID-19 vaccine is the second vaccine to be green-lit by regulators in Europe, following the Pfizer-BioNTech COVID-19 vaccine.

A global team of researchers arrived Thursday in the Chinese city where the coronavirus pandemic was first detected to conduct a politically sensitive investigation into its origins amid uncertainty about whether Beijing might try to prevent embarrassing discoveries.

The group sent to Wuhan by the World Health Organization was approved by President Xi Jinping’s government after months of diplomatic wrangling that prompted an unusual public complaint by the head of WHO.

Scientists suspect the virus that has killed more than 1.9 million people since late 2019 jumped to humans from bats or other animals, most likely in China’s southwest. The ruling Communist Party, stung by complaints it allowed the disease to spread, says the virus came from abroad, possibly on imported seafood, but international scientists reject that.

ExploreUnited Nations marks 75th anniversary under cloud of coronavirus

Fifteen team members were to arrive in Wuhan on Thursday, but two tested positive for coronavirus antibodies before leaving Singapore and were being retested there, WHO said in a statement on Twitter.

The rest of the team arrived at the Wuhan airport and walked through a makeshift clear plastic tunnel into the airport. The researchers, who wore face masks, were greeted by airport staff in full protective gear, including masks, goggles and full body suits.

They will undergo a two-week quarantine as well as a throat swab test and an antibody test for COVID-19, according to CGTN, the English-language channel of state broadcaster CCTV. They are to start working with Chinese experts via video conference while in quarantine.

The team includes virus and other experts from the United States, Australia, Germany, Japan, Britain, Russia, the Netherlands, Qatar and Vietnam.

A government spokesman said this week they will “exchange views” with Chinese scientists but gave no indication whether they would be allowed to gather evidence.

China rejected demands for an international investigation after the Trump administration blamed Beijing for the virus’s spread, which plunged the global economy into its deepest slump since the 1930s.

After Australia called in April for an independent inquiry, Beijing retaliated by blocking imports of Australian beef, wine and other goods.

One possibility is that a wildlife poacher might have passed the virus to traders who carried it to Wuhan, one of the WHO team members, zoologist Peter Daszak of the U.S. group EcoHealth Alliance, told The Associated Press in November.

A single visit by scientists is unlikely to confirm the virus’s origins; pinning down an outbreak’s animal reservoir is typically an exhaustive endeavor that takes years of research including taking animal samples, genetic analysis and epidemiological studies.

“The government should be very transparent and collaborative,” said Shin-Ru Shih, director at the Research Center for Emerging Viral Infections at Taiwan’s Chang Gung University.

The Chinese government has tried to stir confusion about the virus’s origin. It has promoted theories, with little evidence, that the outbreak might have started with imports of tainted seafood, a notion rejected by international scientists and agencies.

“The WHO will need to conduct similar investigations in other places,” an official of the National Health Commission, Mi Feng, said Wednesday.

Some members of the WHO team were en route to China a week ago but had to turn back after Beijing announced they hadn’t received valid visas.

That might have been a “bureaucratic bungle,” but the incident “raises the question if the Chinese authorities were trying to interfere,” said Adam Kamradt-Scott, a health expert at the University of Sydney.

A possible focus for investigators is the Wuhan Institute of Virology in the city where the outbreak first emerged. One of China’s top virus research labs, it built an archive of genetic information about bat coronaviruses after the 2003 outbreak of Severe Acute Respiratory Syndrome.

According to WHO’s published agenda for its origins research, there are no plans to assess whether there might have been an accidental release of the coronavirus at the Wuhan lab, as some American politicians, including President Donald Trump, have claimed.

A “scientific audit” of Institute records and safety measures would be a “routine activity,” said Mark Woolhouse, an epidemiologist at the University of Edinburgh. He said that depends on how willing Chinese authorities are to share information.

“There’s a big element of trust here,” Woolhouse said.

An AP investigation found the government imposed controls on research into the outbreak and bars scientists from speaking to reporters.

The coronavirus’s exact origin may never be traced because viruses change quickly, Woolhouse said.

A year after the virus was first detected in Wuhan, the city is now bustling, with few signs that it was once the epicenter of the outbreak in China. But some residents say they’re still eager to learn about its origin.

“We locals care about this very much. We are curious where the pandemic came from and what the situation was. We live here so we are keen to

know,” said Qin Qiong, owner of a chain of restaurants serving hot and sour noodles. She said she trusts in science to solve the question.

Although it may be challenging to find precisely the same COVID-19 virus in animals as in humans, discovering closely related viruses might help explain how the disease first jumped from animals and clarify what preventive measures are needed to avoid future epidemics.

Scientists should focus instead on making a “comprehensive picture” of the virus to help respond to future outbreaks, Woolhouse said.

“Now is not the time to blame anyone,” Shih said. “We shouldn’t say, it’s your fault.”

The Associated Press contributed to this report.

In Other News